Results · Apr-Jun 2026 · filed 7 Aug 2026
CARE Ratings Q1 FY27 results
StrongStrong: sales up 10% or more & profit up 20% or more on the same quarter last year, with a wider operating margin.
Sales grew 19% to ₹112 crore from ₹93.9 crore in Apr-Jun 2025.
Operating profit grew 25% to ₹34.6 crore, an operating margin of 31.0% (up 1.5 points from a year ago).
Net profit grew 25% to ₹33 crore from ₹26.5 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −15%, net profit −38%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 111.7 | 93.9 | +19% |
| Operating profit (EBITDA) | 34.6 | 27.7 | +25% |
| Operating margin | 31.0% | 29.5% | +1.5 pts |
| Net profit | 33.0 | 26.5 | +25% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 8 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 7 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 7 Aug 2026Outcome Of The Meeting Of The Board Of Directors Of CARE Ratings Limited Held On August 7, 2026
- 7 Aug 2026Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of CARE Ratings Limited Held On August 7, 2026
- 5 Aug 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.